Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Napec announces acquisition and financing

<< Previous

Bullboard Posts

Next >>

Comment by pitbul13on Nov 09, 2016 5:07pm

151 Views

Post# 25442301

RE:RE:Napec announces acquisition and financing

Even in a bought deal, the underwriters can do what is typically called a clean-up sale, where they will sell the shares at a discount to the offering price in order to get it off their books.

Obviously NAPEC would still get them same amount of $$, but this allows the underwriters to reduce their liability.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market